SERB /
Y-mAbs
SERB and Y-mAbs Therapeutics move forward with merger agreement
Source for the buyer and target: Y-mAbs Therapeutics, Inc.
For the buyer and target.
“Beginning on April 21, 2025 and continuing until the execution of the Merger Agreement, Y-mAbs made additional confidential information about Y-mAbs and its businesses available to SERB and the then-interested potentially interested parties and their respective advisors through a virtual data room to permit each party and its advisors to conduct its due diligence reviews.”
Published 18 Aug 2025
Open the sourceWhat happened
Y-mAbs Therapeutics, Inc. disclosed a merger agreement involving SERB. The filing describes a tender offer followed by a merger, subject to the agreement’s conditions. [01]
Terms weren't disclosed. [01]
The source
Everything on this page comes from the source below, quoted word for word.
SERB and Y-mAbs Therapeutics move forward with merger agreement
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly